FutureNeuro Header image

FutureNeuro partners with Ergo to develop e-Health technology for people with epilepsy

Thursday, 11 October 2018 – FutureNeuro, the SFI Research Centre for chronic and rare neurological conditions based at RCSI, has announced its partnership with Irish Cloud solution provider Ergo to enhance crucial eHealth infrastructure in Ireland and provide improved monitoring for people living with epilepsy. The research will provide a voice-based user interface for an…

FutureNeuro Summer Students reflect on their Summer in the Centre

 FutureNeuro Summer Students share their experience of working in an SFI Research Centre The RCSI Summer Studentship encourages the early development research skills for undergraduate students. This was FutureNeuro’s first time welcoming students to our new SFI research centre, and to RCSI. In the middle of June, we welcomed Jack Banks, Sorcha Lynch, Sarah O’Grady…

FutureNeuro RGB

FutureNeuro announces collaboration with Janssen to conduct pre-clinical studies on potential disease-modifying therapies targeting neuroinflammation

FutureNeuro announces collaboration with Janssen to conduct pre-clinical studies on potential disease-modifying therapies targeting neuroinflammation Joint research will evaluate in preclinical models the impact of compounds on inflammation in the brain, which is thought to be an underlying mechanism of epilepsy FutureNeuro, the SFI Research Centre for Chronic and Rare Neurological diseases based at RCSI,…

Meet the FutureNeuro and RCSI Research Summer Students

Meet The FutureNeuro Centres 2018 RCSI Summer Students!   The FutureNeuro Centre are delighted to be participating in the Royal College of Surgeons Research Summer School for the first time. The Research Summer School Programme provides undergraduate students an opportunity to become involved in research projects during the summer months. The four students chosen by…

epiexchange

A community building event for epilepsy research

 Seven large EU-funded projects have joined forces – epiXchange 2018 brings together Europe’s best brains to pave the way for future epilepsy research. Around 50 million people worldwide suffer from epilepsy, making it one of the most common neurological diseases. To decrease this figure and pave the way for future ground-breaking epilepsy research, seven large…

FutureNeuro RGB

FutureNeuro and GreenLight Medicines partner to develop new cannabis-based treatments for epilepsy

Novel cannabinoids could provide new therapy options for patients with drug-resistant epilepsy   A new partnership between FutureNeuro, the SFI Research Centre for Chronic and Rare Neurological diseases based at RCSI and GreenLight Medicines, an indigenous Irish biopharmaceutical company has been formed to develop new cannabis-based treatments for drug resistant epilepsies, and in particular, childhood…

FutureNeuro RGB

RCSI enters research agreement to identify genetic targets for childhood epilepsies

Breakthroughs in understanding brain chemistry point to new drug targets Developing new treatments for childhood epilepsies and neuro-developmental diseases is the aim of a new partnership between RCSI (FutureNeuro, the SFI Research Centre for chronic and rare neurological diseases based at the Royal College of Surgeons in Ireland) and F. Hoffmann-La Roche Ltd. announced today….